Method for screening glioma biomarker based on PTEN gene state
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- BEIJING INSTITUTE OF TECHNOLOGYGY
- Publication Date
- 2020-12-11
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of molecular biology technology and computer, and relates to a method for screening glioma biomarkers based on PTEN gene status. Background technique
[0002] Glioma is the most common adult primary brain tumor. Glioma is classified into astrocytoma, oligodendroglioma, and ependymoma according to its histological manifestations. The World Health Organization (WHO) classifies gliomas as Divided into I, II, III and IV grades, the higher the grade, the stronger the invasiveness. Grade IV gliomas, glioblastoma multiforme (GBM), are the most aggressive and high-grade malignant tumors. The 1- and 5-year overall survival rates for high-grade gliomas are 40% and 10%, respectively. The high mortality rate of glioma is due to its aggressiveness and high recurrence rate. The heterogeneity of gliomas did not improve patient survival despite treatment with surgery, radiotherapy, and alkylating chemotherapy. Major advances in g...